Minimal Effects of Cariprazine on Prolactin Levels in Bipolar Disorder and Schizophrenia
Larry Culpepper,Eduard Vieta,Deanna L Kelly,Mehul D Patel,Balázs Szatmári,Arlene Hankinson,Willie R Earley
DOI: https://doi.org/10.2147/NDT.S348143
IF: 2.989
2022-05-12
Neuropsychiatric Disease and Treatment
Abstract:Larry Culpepper, 1 Eduard Vieta, 2 Deanna L Kelly, 3 Mehul D Patel, 4 Balázs Szatmári, 5 Arlene Hankinson, 4 Willie R Earley 4 1 Boston University School of Medicine, Boston, MA, USA; 2 Hospital Clinic, Institute of Neuroscience, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain; 3 Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD, USA; 4 AbbVie, Madison, NJ, USA; 5 Gedeon Richter Plc., Budapest, Hungary Correspondence: Larry Culpepper, Boston University School of Medicine, 90 Sylvia Lane, Westport, MA, 02790-1406, USA, Tel +1 617 414-6225, Email Background: Many medications used to treat schizophrenia and bipolar I disorder are linked to hyperprolactinemia. The effects of cariprazine, a dopamine D 3 /D 2 receptor partial agonist, on prolactin levels in patients with schizophrenia or bipolar I disorder were evaluated. Methods: Effects on prolactin were evaluated using pooled data from randomized, double-blind, placebo-controlled studies in patients with schizophrenia (4 studies; 6-week duration; cariprazine 1.5– 3 mg/d, 4.5– 6 mg/d, and 9– 12 mg/d), bipolar mania (3 studies; 3-week duration; cariprazine 3– 6 and 9– 12 mg/d), and bipolar depression (3 studies; 6- to 8-week duration; cariprazine 1.5 and 3 mg/d). Long-term effects were analyzed using open-label studies in patients with schizophrenia (2 studies; 48-week duration) and patients with bipolar mania (1 study; 16-week duration). Change in prolactin levels (ng/mL) from baseline to study endpoint was evaluated in subsets of sex and prior medication use. Results: In patients with schizophrenia (male, n = 1377; female, n = 558), median prolactin changes were − 1.2 for males and − 7.4 for females on placebo, and ranged from − 4.2 to − 3.6 for males and − 12.4 to +0.2 for females in the cariprazine-treatment groups. In patients with bipolar mania (male, n = 570; female, n = 395), median prolactin changes were − 0.2 for males and − 1.1 for females on placebo and ranged from − 2.1 to − 3.0 for males and 0 to +1.8 for females in the cariprazine-treatment groups. Median decreases were also seen in the long-term studies of schizophrenia (range, − 14.6 to − 2.0) and bipolar mania (range, − 0.8 to +1.9). In patients with bipolar depression (male, n = 485; female, n = 780), median prolactin changes were +0.3 for males and +0.7 for females on placebo and ranged from +0.4 to +0.5 for males and +3.0 to +3.1 for females in the cariprazine-treatment groups. Conclusion: Treatment with cariprazine for schizophrenia or bipolar I disorder was associated with minimal effects on prolactin levels. Keywords: dopamine, serotonin, mania, depression, prolactin Schizophrenia and bipolar disorder are severe, chronic, and heterogeneous disorders that impact the health, social, and economic well-being of patients, families, caregivers, and society. Pharmacotherapy can treat and manage these disorders; however, many drugs used in the treatment of schizophrenia and bipolar disorder act as antagonists at dopamine D 2 receptors, a mechanism that has been linked to hyperprolactinemia (elevated prolactin levels). 1,2 Prolactin is a peptide hormone secreted by the pituitary gland based on a circadian pattern (eg, prolactin levels peak overnight and are approximately 1.5- to 2-fold higher than those during the day). 3 The secretion of prolactin is regulated through dopaminergic transmission, as stimulation of dopamine D 2 receptors on lactotroph cells inhibits gene transcription, synthesis, and release of prolactin and lactotroph proliferation. 4 In healthy adults, prolactin levels are generally less than 25 ng/mL; 5 however, there is evidence that normal prolactin levels in men are likely lower (approximately 20 ng/mL), 6 which may be due to the differences in physiology between males and females. In females, the main function of prolactin is the induction of lactation and maintenance of breast milk production; prolactin also plays a role in breast enlargement during pregnancy, inhibition of hypothalamic gonadotrophin-releasing hormone (GnRH), and maintenance of ovarian function and progesterone secretion. Prolactin is naturally elevated in pregnant and lactating women, where levels can increase up to 10- to 20-fold compared with normal levels. 7 In males, the biological role of prolactin is limited; its effects are indirectly related to its regulation of GnRH, which in turn affects spermatogenesis and testosterone levels. 8 Similarly, in developing adolescents, prolactin can indirectly affect sexual development. As su -Abstract Truncated-
psychiatry,clinical neurology